24/10/2012 - 12:00 - Sala 473.10

MDMA and pharmacogenetics in humans: Clinical implications

Scientific sessions, CRG Group Leader Seminars

Rafael de la Torre

Neurosciences Programme, IMIM-Parc de Salut Mar

Rafael de la Torre is a researcher interested in the pharmacology of drugs in humans. He started working in the clinical pharmacology of drugs of abuse. More recently he has been involved in the study of compounds of natural origin and their impact in the prevention of cardiovascular disease as well as their pleiotropic effects as cognitive enhancers in neurodegenerative and genetic diseases leading to intellectual disability. He is the coordinator of the Human Pharmacology and Clinical Neurosciences Research Group and Director of the Neurosciences Research Program at IMIM (Hospital del Mar Medical Research Institute).

In the last 15 years he has been involved in several projects aimed at the clinical pharmacology of the amphetamine-like designer drug MDMA (ecstasy, 3,4-methylenedioxymethamphetamine). Several genetic polymorphisms are involved in the pharmacokinetics and pharmacodynamics of this drug. His talk will focus on the clinical impact of pharmacogenetics in MDMA acute and long-term effects.

The upcoming "Group Leader Seminars" are:


Luciano Di Croce, CRG, November 7

Fatima Gebauer, CRG, November 14 

Group Leaders Seminars are always on Wednesdays at 12:00h at the Auditorium or Sala Marie Curie (exceptionally Aula 473).